Nanoparticles Improve Biological Functions of Phthalocyanine Photosensitizers Used for Photodynamic Therapy

被引:80
作者
Jia, Xiao [1 ]
Jia, Lee [1 ,2 ]
机构
[1] Fuzhou Univ, Coll Chem & Chem Engn, Inst Res Funct Mat, Fuzhou 350002, Peoples R China
[2] Natl Canc Inst, NIH, Dev Therapeut Program, Bethesda, MD 20852 USA
关键词
Photodynamic therapy; phthalocyanine photosensitizers; nanoparticles; nanocarriers; drug delivery; HEXADECAFLUORO ZINC PHTHALOCYANINE; CARBON NANOTUBES; PLGA NANOPARTICLES; GOLD NANOPARTICLES; SINGLET OXYGEN; QUANTUM DOTS; DELIVERY; VIVO; GENERATION;
D O I
10.2174/138920012802850074
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Photodynamic therapy (PDT) is a new technology using photodynamic effect for disease diagnosis and treatment. It is a two-step technique involving the uptake of a photosensitizer by cancer tissue followed by light irradiation that excites the photosensitizer to produce highly reactive oxygen species, the latter execute apoptosis of cancerous cells. As a second-generation of photosensitizers, phthalocyanine demonstrates higher absorption in the 650-800nm range and short tissue accumulation compared to their first generation. However, many potent phthalocyanine photosensitizers are hydrophobic and poorly water-soluble, which limit their therapeutic applications. As a result, advanced delivery systems and different strategies are called for to improve the effectiveness of PDT. Facts have proved that using nanoparticles as carries of photosensitizers is a very promising route. Nanoparticles have the potentials to increase photosensitizers' aqueous solubility, bioavailability and stability, and deliver photosensitizers to the target tissues. This article reviewed the commonly-used nanoparticles, including colloid gold, quantum dots, paramagnetic nanoparticles, silica-based materials, polymer-based nanoparticles, as potential delivery systems for phthalocyanine photosensitizers, and summarized the improved biological functions of phthalocyanine photosensitizers in PDT.
引用
收藏
页码:1119 / 1122
页数:4
相关论文
共 42 条
[1]   PEG-COATED POLY(LACTIC ACID) NANOPARTICLES FOR THE DELIVERY OF HEXADECAFLUORO ZINC PHTHALOCYANINE TO EMT-6 MOUSE MAMMARY-TUMORS [J].
ALLEMANN, E ;
BRASSEUR, N ;
BENREZZAK, O ;
ROUSSEAU, J ;
KUDREVICH, SV ;
BOYLE, RW ;
LEROUX, JC ;
GURNY, R ;
VANLIER, JE .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (05) :382-387
[2]  
Allemann E, 1996, INT J CANCER, V66, P821, DOI 10.1002/(SICI)1097-0215(19960611)66:6<821::AID-IJC19>3.0.CO
[3]  
2-5
[4]   Biomedical applications of functionalised carbon nanotubes [J].
Bianco, A ;
Kostarelos, K ;
Partidos, CD ;
Prato, M .
CHEMICAL COMMUNICATIONS, 2005, (05) :571-577
[5]   Applications of carbon nanotubes in drug delivery [J].
Bianco, A ;
Kostarelos, K ;
Prato, M .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2005, 9 (06) :674-679
[6]   The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma [J].
Camerin, Monica ;
Magaraggia, Michela ;
Soncin, Marina ;
Jori, Giulio ;
Moreno, Miguel ;
Chambrier, Isabelle ;
Cook, Michael J. ;
Russell, David A. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (10) :1910-1918
[7]   Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer [J].
Cheng, Yu ;
Samia, Anna C. ;
Meyers, Joseph D. ;
Panagopoulos, Irene ;
Fei, Baowei ;
Burda, Clemens .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (32) :10643-10647
[8]   Deep Penetration of a PDT Drug into Tumors by Noncovalent Drug-Gold Nanoparticle Conjugates [J].
Cheng, Yu ;
Meyers, Joseph D. ;
Broome, Ann-Marie ;
Kenney, Malcolm E. ;
Basilion, James P. ;
Burda, Clemens .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (08) :2583-2591
[9]   Delivery and Efficacy of a Cancer Drug as a Function of the Bond to the Gold Nanoparticle Surface [J].
Cheng, Yu ;
Samia, Anna C. ;
Li, Jun ;
Kenney, Malcolm E. ;
Resnick, Andrew ;
Burda, Clemens .
LANGMUIR, 2010, 26 (04) :2248-2255
[10]   Preparation and characterization of water-soluble pH-sensitive nanocarriers for drug delivery [J].
Dufresne, MH ;
Le Garrec, D ;
Sant, V ;
Leroux, JC ;
Ranger, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 277 (1-2) :81-90